Myriad Genetics
Type: Company
As of November 2026, Myriad Genetics has been mentioned in one podcast episode on The Diary Of A CEO (Apr 2026). Discussed in the context of patenting genes related to cancer.
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient
| Mentioned in | 1 episode on 1 podcast (as of November 2026) |
|---|---|
| First heard | Apr 2026 on The Diary Of A CEO |
| Industry | Biotechnology |
| Headquarters | United States |
| Website | myriad.com |
Who talks about Myriad Genetics on podcasts?
Myriad Genetics came up; the most recent mention was Apr 2026 on The Diary Of A CEO.
What is Myriad Genetics mentioned alongside?
Myriad Genetics is most often mentioned alongside Compounding pharmacy, Insulin and Obesity.
Mentioned together: Compounding pharmacy, Insulin, Obesity, BPC-157, TBI, Fertility, insulin sensitivity, Channing Tatum, FDA, GLP-1